Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

44.58
Delayed Data
As of 12:59pm ET
 +0.127 / +0.29%
Today’s Change
27.14
Today|||52-Week Range
80.71
-43.84%
Year-to-Date
No recent news for Alkermes Plc.

Today’s Trading

Previous close44.45
Today’s open44.56
Day’s range43.99 - 44.99
Volume487,115
Average volume (3 months)969,021
Market cap$6.7B
Dividend yield--
Data as of 12:59pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)-623.81%
Earnings growth (this year)+48.35%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+1.54%
P/E ratioNM
Price/Sales18.85
Price/Book5.10

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-0.06-0.13%
ALNYAlnylam Pharmaceutic...+0.66+0.93%
RDYDr.Reddy's Laborator...+0.51+1.11%
JAZZJazz Pharmaceuticals...-0.70-0.54%
Data as of 1:14pm ET, 08/25/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$628.3M
Annual profit (last year)-$227.2M
Net profit margin-36.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs